APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exosome Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Exosome Service Market Analysis and Forecast 2026-2032

30 January 2026208 pages

Choose your research edition.

Industry ResearchExosome Service Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Exosome Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome Service Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome Service Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Exosome Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Exosome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Exosome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Exosome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Exosome Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Exosome Service include LipExoGen Biotech, Creative Biostructure, Immunostep Biotech, AMSBIO, Frontage Labs, EVerZom, System Biosicences (SBI), Exosome Diagnostics and Creative Bioarray, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Exosome Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Exosome Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Exosome Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Exosome Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Exosome Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Exosome Service revenue, projected growth trends, production technology, application and end-user industry.

Exosome Service Segment by Company

LipExoGen Biotech

Creative Biostructure

Immunostep Biotech

AMSBIO

Frontage Labs

EVerZom

System Biosicences (SBI)

Exosome Diagnostics

Creative Bioarray

Exosomics

Creative Proteomics

RoosterBio

Clara Biotech

Luminous BioSciences

Capital Biosciences

Anazao

Alpha Nano Tech

NCELL

Wayen Biotechnologies (Shanghai)

Shanghai Yanjiang Biotechnology

Exosome Service Segment by Type

Exosome Isolation

Exosome Identification

Exosome Analysis

Other

Exosome Service Segment by Application

Medicine

Biological

Other

Exosome Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Exosome Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Exosome Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Exosome Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Exosome Isolation Major Player Table 3. Exosome Identification Major Player Table 4. Exosome Analysis Major Player Table 5. Other Major Player Table 6. Global Exosome Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Medicine Major Player Table 8. Biological Major Player Table 9. Other Major Player Table 10. Exosome Service Industry Trends Table 11. Exosome Service Industry Drivers Table 12. Exosome Service Industry Opportunities and Challenges Table 13. Exosome Service Industry Restraints Table 14. Global Exosome Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Exosome Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Exosome Service Market Share by Region (2021-2026) Table 17. Global Exosome Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Exosome Service Market Share by Region (2027-2032) Table 19. Global Exosome Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Exosome Service Revenue Market Share by Players (2021-2026) Table 21. Global Exosome Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Exosome Service Key Players Headquarters & Area Served Table 23. Global Exosome Service Players, Product Type & Application Table 24. Global Exosome Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Exosome Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Exosome Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Exosome Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Exosome Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Exosome Service Revenue Market Share by Type (2021-2026) Table 31. Global Exosome Service Revenue Market Share by Type (2027-2032) Table 32. Global Exosome Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Exosome Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Exosome Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Exosome Service Revenue Market Share by Application (2021-2026) Table 36. Global Exosome Service Revenue Market Share by Application (2027-2032) Table 37. LipExoGen Biotech Company Information Table 38. LipExoGen Biotech Business Overview Table 39. LipExoGen Biotech Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. LipExoGen Biotech Exosome Service Product Portfolio Table 41. LipExoGen Biotech Recent Development Table 42. Creative Biostructure Company Information Table 43. Creative Biostructure Business Overview Table 44. Creative Biostructure Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Creative Biostructure Exosome Service Product Portfolio Table 46. Creative Biostructure Recent Development Table 47. Immunostep Biotech Company Information Table 48. Immunostep Biotech Business Overview Table 49. Immunostep Biotech Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Immunostep Biotech Exosome Service Product Portfolio Table 51. Immunostep Biotech Recent Development Table 52. AMSBIO Company Information Table 53. AMSBIO Business Overview Table 54. AMSBIO Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. AMSBIO Exosome Service Product Portfolio Table 56. AMSBIO Recent Development Table 57. Frontage Labs Company Information Table 58. Frontage Labs Business Overview Table 59. Frontage Labs Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Frontage Labs Exosome Service Product Portfolio Table 61. Frontage Labs Recent Development Table 62. EVerZom Company Information Table 63. EVerZom Business Overview Table 64. EVerZom Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. EVerZom Exosome Service Product Portfolio Table 66. EVerZom Recent Development Table 67. System Biosicences (SBI) Company Information Table 68. System Biosicences (SBI) Business Overview Table 69. System Biosicences (SBI) Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. System Biosicences (SBI) Exosome Service Product Portfolio Table 71. System Biosicences (SBI) Recent Development Table 72. Exosome Diagnostics Company Information Table 73. Exosome Diagnostics Business Overview Table 74. Exosome Diagnostics Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Exosome Diagnostics Exosome Service Product Portfolio Table 76. Exosome Diagnostics Recent Development Table 77. Creative Bioarray Company Information Table 78. Creative Bioarray Business Overview Table 79. Creative Bioarray Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Creative Bioarray Exosome Service Product Portfolio Table 81. Creative Bioarray Recent Development Table 82. Exosomics Company Information Table 83. Exosomics Business Overview Table 84. Exosomics Exosome Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Exosomics Exosome Service Product Portfolio Table 86. Exosomics Recent Development Table 87. Creative Proteomics Company Information Table 88. Creative Proteomics Business Overview Table 89. Creative Proteomics Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Creative Proteomics Exosome Service Product Portfolio Table 91. Creative Proteomics Recent Development Table 92. RoosterBio Company Information Table 93. RoosterBio Business Overview Table 94. RoosterBio Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. RoosterBio Exosome Service Product Portfolio Table 96. RoosterBio Recent Development Table 97. Clara Biotech Company Information Table 98. Clara Biotech Business Overview Table 99. Clara Biotech Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Clara Biotech Exosome Service Product Portfolio Table 101. Clara Biotech Recent Development Table 102. Luminous BioSciences Company Information Table 103. Luminous BioSciences Business Overview Table 104. Luminous BioSciences Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Luminous BioSciences Exosome Service Product Portfolio Table 106. Luminous BioSciences Recent Development Table 107. Capital Biosciences Company Information Table 108. Capital Biosciences Business Overview Table 109. Capital Biosciences Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Capital Biosciences Exosome Service Product Portfolio Table 111. Capital Biosciences Recent Development Table 112. Anazao Company Information Table 113. Anazao Business Overview Table 114. Anazao Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Anazao Exosome Service Product Portfolio Table 116. Anazao Recent Development Table 117. Alpha Nano Tech Company Information Table 118. Alpha Nano Tech Business Overview Table 119. Alpha Nano Tech Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Alpha Nano Tech Exosome Service Product Portfolio Table 121. Alpha Nano Tech Recent Development Table 122. NCELL Company Information Table 123. NCELL Business Overview Table 124. NCELL Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. NCELL Exosome Service Product Portfolio Table 126. NCELL Recent Development Table 127. Wayen Biotechnologies (Shanghai) Company Information Table 128. Wayen Biotechnologies (Shanghai) Business Overview Table 129. Wayen Biotechnologies (Shanghai) Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Wayen Biotechnologies (Shanghai) Exosome Service Product Portfolio Table 131. Wayen Biotechnologies (Shanghai) Recent Development Table 132. Shanghai Yanjiang Biotechnology Company Information Table 133. Shanghai Yanjiang Biotechnology Business Overview Table 134. Shanghai Yanjiang Biotechnology Exosome Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Shanghai Yanjiang Biotechnology Exosome Service Product Portfolio Table 136. Shanghai Yanjiang Biotechnology Recent Development Table 137. North America Exosome Service Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Exosome Service Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Exosome Service Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Exosome Service Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Exosome Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Exosome Service Revenue by Country (2021-2026) & (US$ Million) Table 143. North America Exosome Service Revenue by Country (US$ Million) & (2027-2032) Table 144. Europe Exosome Service Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Exosome Service Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Exosome Service Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Exosome Service Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Exosome Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Exosome Service Revenue by Country (2021-2026) & (US$ Million) Table 150. Europe Exosome Service Revenue by Country (US$ Million) & (2027-2032) Table 151. China Exosome Service Revenue by Type (2021-2026) & (US$ Million) Table 152. China Exosome Service Revenue by Type (2027-2032) & (US$ Million) Table 153. China Exosome Service Revenue by Application (2021-2026) & (US$ Million) Table 154. China Exosome Service Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Exosome Service Revenue by Type (2021-2026) & (US$ Million) Table 156. Asia Exosome Service Revenue by Type (2027-2032) & (US$ Million) Table 157. Asia Exosome Service Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Exosome Service Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Exosome Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Exosome Service Revenue by Region (US$ Million) & (2021-2026) Table 161. Asia Exosome Service Revenue by Region (US$ Million) & (2027-2032) Table 162. SAMEA Exosome Service Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Exosome Service Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Exosome Service Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Exosome Service Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Exosome Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Exosome Service Revenue by Country (2021-2026) & (US$ Million) Table 168. SAMEA Exosome Service Revenue by Country (US$ Million) & (2027-2032) Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Exosome Service Image Figure 2. Global Exosome Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exosome Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Exosome Isolation Image Figure 5. Exosome Identification Image Figure 6. Exosome Analysis Image Figure 7. Other Image Figure 8. Global Exosome Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Exosome Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Medicine Image Figure 11. Biological Image Figure 12. Other Image Figure 13. Global Exosome Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Exosome Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Exosome Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Exosome Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Exosome Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Exosome Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Exosome Service Revenue Market Share by Type (2021-2032) Figure 21. Global Exosome Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Exosome Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Exosome Service Revenue Market Share by Application (2021-2032) Figure 24. North America Exosome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Exosome Service Revenue Share by Type (2021-2032) Figure 26. North America Exosome Service Revenue Share by Application (2021-2032) Figure 27. North America Exosome Service Revenue Share by Country (2021-2032) Figure 28. United States Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Exosome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Exosome Service Revenue Share by Type (2021-2032) Figure 33. Europe Exosome Service Revenue Share by Application (2021-2032) Figure 34. Europe Exosome Service Revenue Share by Country (2021-2032) Figure 35. Germany Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Exosome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Exosome Service Revenue Share by Type (2021-2032) Figure 45. China Exosome Service Revenue Share by Application (2021-2032) Figure 46. Asia Exosome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Exosome Service Revenue Share by Type (2021-2032) Figure 48. Asia Exosome Service Revenue Share by Application (2021-2032) Figure 49. Asia Exosome Service Revenue Share by Region (2021-2032) Figure 50. Japan Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Exosome Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Exosome Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Exosome Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Exosome Service Revenue Share by Country (2021-2032) Figure 60. Brazil Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Exosome Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Exosome Isolation
  • Exosome Identification
  • Exosome Analysis
  • Other
Applications
  • Medicine
  • Biological
  • Other
Companies covered
  • LipExoGen Biotech
  • Creative Biostructure
  • Immunostep Biotech
  • AMSBIO
  • Frontage Labs
  • EVerZom
  • System Biosicences (SBI)
  • Exosome Diagnostics
  • Creative Bioarray
  • Exosomics
  • Creative Proteomics
  • RoosterBio
  • Clara Biotech
  • Luminous BioSciences
  • Capital Biosciences
  • Anazao
  • Alpha Nano Tech
  • NCELL
  • Wayen Biotechnologies (Shanghai)
  • Shanghai Yanjiang Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Exosome Service Market by Type
  3. 1.2.1 Global Exosome Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Exosome Isolation
  5. 1.2.3 Exosome Identification
  6. 1.2.4 Exosome Analysis
  7. 1.2.5 Other
  8. 1.3 Exosome Service Market by Application
  9. 1.3.1 Global Exosome Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Medicine
  11. 1.3.3 Biological
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Exosome Service Market Dynamics
  1. 2.1 Exosome Service Industry Trends
  2. 2.2 Exosome Service Industry Drivers
  3. 2.3 Exosome Service Industry Opportunities and Challenges
  4. 2.4 Exosome Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Exosome Service Market Perspective (2021-2032)
  2. 3.2 Global Exosome Service Growth Trends by Region
  3. 3.2.1 Global Exosome Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Exosome Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Exosome Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Exosome Service Revenue by Players
  2. 4.1.1 Global Exosome Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Exosome Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Exosome Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Exosome Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Exosome Service Key Players Headquarters & Area Served
  7. 4.4 Global Exosome Service Players, Product Type & Application
  8. 4.5 Global Exosome Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Exosome Service Market CR5 and HHI
  11. 4.6.3 2025 Exosome Service Tier 1, Tier 2, and Tier 3
5 Exosome Service Market Size by Type
  1. 5.1 Global Exosome Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Exosome Service Revenue by Type (2021-2032)
  3. 5.3 Global Exosome Service Revenue Market Share by Type (2021-2032)
6 Exosome Service Market Size by Application
  1. 6.1 Global Exosome Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Exosome Service Revenue by Application (2021-2032)
  3. 6.3 Global Exosome Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 LipExoGen Biotech
  2. 7.1.1 LipExoGen Biotech Company Information
  3. 7.1.2 LipExoGen Biotech Business Overview
  4. 7.1.3 LipExoGen Biotech Exosome Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 LipExoGen Biotech Exosome Service Product Portfolio
  6. 7.1.5 LipExoGen Biotech Recent Developments
  7. 7.2 Creative Biostructure
  8. 7.2.1 Creative Biostructure Company Information
  9. 7.2.2 Creative Biostructure Business Overview
  10. 7.2.3 Creative Biostructure Exosome Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Creative Biostructure Exosome Service Product Portfolio
  12. 7.2.5 Creative Biostructure Recent Developments
  13. 7.3 Immunostep Biotech
  14. 7.3.1 Immunostep Biotech Company Information
  15. 7.3.2 Immunostep Biotech Business Overview
  16. 7.3.3 Immunostep Biotech Exosome Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Immunostep Biotech Exosome Service Product Portfolio
  18. 7.3.5 Immunostep Biotech Recent Developments
  19. 7.4 AMSBIO
  20. 7.4.1 AMSBIO Company Information
  21. 7.4.2 AMSBIO Business Overview
  22. 7.4.3 AMSBIO Exosome Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AMSBIO Exosome Service Product Portfolio
  24. 7.4.5 AMSBIO Recent Developments
  25. 7.5 Frontage Labs
  26. 7.5.1 Frontage Labs Company Information
  27. 7.5.2 Frontage Labs Business Overview
  28. 7.5.3 Frontage Labs Exosome Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Frontage Labs Exosome Service Product Portfolio
  30. 7.5.5 Frontage Labs Recent Developments
  31. 7.6 EVerZom
  32. 7.6.1 EVerZom Company Information
  33. 7.6.2 EVerZom Business Overview
  34. 7.6.3 EVerZom Exosome Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 EVerZom Exosome Service Product Portfolio
  36. 7.6.5 EVerZom Recent Developments
  37. 7.7 System Biosicences (SBI)
  38. 7.7.1 System Biosicences (SBI) Company Information
  39. 7.7.2 System Biosicences (SBI) Business Overview
  40. 7.7.3 System Biosicences (SBI) Exosome Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 System Biosicences (SBI) Exosome Service Product Portfolio
  42. 7.7.5 System Biosicences (SBI) Recent Developments
  43. 7.8 Exosome Diagnostics
  44. 7.8.1 Exosome Diagnostics Company Information
  45. 7.8.2 Exosome Diagnostics Business Overview
  46. 7.8.3 Exosome Diagnostics Exosome Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Exosome Diagnostics Exosome Service Product Portfolio
  48. 7.8.5 Exosome Diagnostics Recent Developments
  49. 7.9 Creative Bioarray
  50. 7.9.1 Creative Bioarray Company Information
  51. 7.9.2 Creative Bioarray Business Overview
  52. 7.9.3 Creative Bioarray Exosome Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Bioarray Exosome Service Product Portfolio
  54. 7.9.5 Creative Bioarray Recent Developments
  55. 7.10 Exosomics
  56. 7.10.1 Exosomics Company Information
  57. 7.10.2 Exosomics Business Overview
  58. 7.10.3 Exosomics Exosome Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Exosomics Exosome Service Product Portfolio
  60. 7.10.5 Exosomics Recent Developments
  61. 7.11 Creative Proteomics
  62. 7.11.1 Creative Proteomics Company Information
  63. 7.11.2 Creative Proteomics Business Overview
  64. 7.11.3 Creative Proteomics Exosome Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Creative Proteomics Exosome Service Product Portfolio
  66. 7.11.5 Creative Proteomics Recent Developments
  67. 7.12 RoosterBio
  68. 7.12.1 RoosterBio Company Information
  69. 7.12.2 RoosterBio Business Overview
  70. 7.12.3 RoosterBio Exosome Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 RoosterBio Exosome Service Product Portfolio
  72. 7.12.5 RoosterBio Recent Developments
  73. 7.13 Clara Biotech
  74. 7.13.1 Clara Biotech Company Information
  75. 7.13.2 Clara Biotech Business Overview
  76. 7.13.3 Clara Biotech Exosome Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Clara Biotech Exosome Service Product Portfolio
  78. 7.13.5 Clara Biotech Recent Developments
  79. 7.14 Luminous BioSciences
  80. 7.14.1 Luminous BioSciences Company Information
  81. 7.14.2 Luminous BioSciences Business Overview
  82. 7.14.3 Luminous BioSciences Exosome Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Luminous BioSciences Exosome Service Product Portfolio
  84. 7.14.5 Luminous BioSciences Recent Developments
  85. 7.15 Capital Biosciences
  86. 7.15.1 Capital Biosciences Company Information
  87. 7.15.2 Capital Biosciences Business Overview
  88. 7.15.3 Capital Biosciences Exosome Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Capital Biosciences Exosome Service Product Portfolio
  90. 7.15.5 Capital Biosciences Recent Developments
  91. 7.16 Anazao
  92. 7.16.1 Anazao Company Information
  93. 7.16.2 Anazao Business Overview
  94. 7.16.3 Anazao Exosome Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Anazao Exosome Service Product Portfolio
  96. 7.16.5 Anazao Recent Developments
  97. 7.17 Alpha Nano Tech
  98. 7.17.1 Alpha Nano Tech Company Information
  99. 7.17.2 Alpha Nano Tech Business Overview
  100. 7.17.3 Alpha Nano Tech Exosome Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Alpha Nano Tech Exosome Service Product Portfolio
  102. 7.17.5 Alpha Nano Tech Recent Developments
  103. 7.18 NCELL
  104. 7.18.1 NCELL Company Information
  105. 7.18.2 NCELL Business Overview
  106. 7.18.3 NCELL Exosome Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 NCELL Exosome Service Product Portfolio
  108. 7.18.5 NCELL Recent Developments
  109. 7.19 Wayen Biotechnologies (Shanghai)
  110. 7.19.1 Wayen Biotechnologies (Shanghai) Company Information
  111. 7.19.2 Wayen Biotechnologies (Shanghai) Business Overview
  112. 7.19.3 Wayen Biotechnologies (Shanghai) Exosome Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Wayen Biotechnologies (Shanghai) Exosome Service Product Portfolio
  114. 7.19.5 Wayen Biotechnologies (Shanghai) Recent Developments
  115. 7.20 Shanghai Yanjiang Biotechnology
  116. 7.20.1 Shanghai Yanjiang Biotechnology Company Information
  117. 7.20.2 Shanghai Yanjiang Biotechnology Business Overview
  118. 7.20.3 Shanghai Yanjiang Biotechnology Exosome Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Shanghai Yanjiang Biotechnology Exosome Service Product Portfolio
  120. 7.20.5 Shanghai Yanjiang Biotechnology Recent Developments
8 North America
  1. 8.1 North America Exosome Service Revenue (2021-2032)
  2. 8.2 North America Exosome Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Exosome Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Exosome Service Revenue by Type (2027-2032)
  5. 8.3 North America Exosome Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Exosome Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Exosome Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Exosome Service Revenue by Application (2027-2032)
  9. 8.5 North America Exosome Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Exosome Service Revenue by Country
  11. 8.6.1 North America Exosome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Exosome Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Exosome Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Exosome Service Revenue (2021-2032)
  2. 9.2 Europe Exosome Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Exosome Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Exosome Service Revenue by Type (2027-2032)
  5. 9.3 Europe Exosome Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Exosome Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Exosome Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Exosome Service Revenue by Application (2027-2032)
  9. 9.5 Europe Exosome Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Exosome Service Revenue by Country
  11. 9.6.1 Europe Exosome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Exosome Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Exosome Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Exosome Service Revenue (2021-2032)
  2. 10.2 China Exosome Service Revenue by Type (2021-2032)
  3. 10.2.1 China Exosome Service Revenue by Type (2021-2026)
  4. 10.2.2 China Exosome Service Revenue by Type (2027-2032)
  5. 10.3 China Exosome Service Revenue Share by Type (2021-2032)
  6. 10.4 China Exosome Service Revenue by Application (2021-2032)
  7. 10.4.1 China Exosome Service Revenue by Application (2021-2026)
  8. 10.4.2 China Exosome Service Revenue by Application (2027-2032)
  9. 10.5 China Exosome Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Exosome Service Revenue (2021-2032)
  2. 11.2 Asia Exosome Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Exosome Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Exosome Service Revenue by Type (2027-2032)
  5. 11.3 Asia Exosome Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Exosome Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Exosome Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Exosome Service Revenue by Application (2027-2032)
  9. 11.5 Asia Exosome Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Exosome Service Revenue by Country
  11. 11.6.1 Asia Exosome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Exosome Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Exosome Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Exosome Service Revenue (2021-2032)
  2. 12.2 SAMEA Exosome Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Exosome Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Exosome Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Exosome Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Exosome Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Exosome Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Exosome Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Exosome Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Exosome Service Revenue by Country
  11. 12.6.1 SAMEA Exosome Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Exosome Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Exosome Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst